KineMed reports plans to price initial public offering of common stock

H.C. Wainwright, MKM Dillon and Dawson James are the joint bookrunners

By Devika Patel

Knoxville, Tenn., Jan. 8 - KineMed, Inc. will conduct an initial public offering of its common stock with a 30-day greenshoe, according to a Form S-1 filed Wednesday with the Securities and Exchange Commission.

H.C. Wainwright & Co., LLC, MKM Dillon and Dawson James Securities are the joint bookrunning managers.

Proceeds will be used for the start-up and development of a laboratory, clinical trials, sales, marketing and business development, working capital and general corporate purposes.

The Emeryville, Calif., company plans to collaborate with pharmaceutical and biotechnology companies to develop diagnostic biomarker tests. It intends to list its common stock on the Nasdaq under the symbol "KNMD."

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.